122 related articles for article (PubMed ID: 3422179)
1. Serum copper in ovarian carcinoma.
Jacobs AJ; Sommers GM; Axelrod JH; Galakatos AE; Kao MS; Camel HM
Cancer; 1988 Mar; 61(5):1015-7. PubMed ID: 3422179
[TBL] [Abstract][Full Text] [Related]
2. CA 15-3 serum levels in ovarian cancer.
Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
[TBL] [Abstract][Full Text] [Related]
3. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
5. A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
Meisel M; Straube W; Weise J; Burkhardt B
Arch Gynecol Obstet; 1995; 256(1):9-15. PubMed ID: 7726659
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in epithelial carcinoma of the ovary].
Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
[No Abstract] [Full Text] [Related]
7. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
[TBL] [Abstract][Full Text] [Related]
8. [Serum CA 125 and ferritin in patients with ovarian carcinoma].
Kanajet D; Klarić P; Filjak K
Jugosl Ginekol Perinatol; 1988; 28(5-6):125-8. PubMed ID: 3216687
[No Abstract] [Full Text] [Related]
9. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
12. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
Koebl H; Tatra G; Bieglmayer C
Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
[TBL] [Abstract][Full Text] [Related]
14. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
15. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
[TBL] [Abstract][Full Text] [Related]
17. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.
Zurawski VR; Knapp RC; Einhorn N; Kenemans P; Mortel R; Ohmi K; Bast RC; Ritts RE; Malkasian G
Gynecol Oncol; 1988 May; 30(1):7-14. PubMed ID: 2452773
[TBL] [Abstract][Full Text] [Related]
18. [Simultaneous determination of Ca 125 and D-dimer in plasma and ascites in ovarian cancer].
Schröck R; Hafter R; Graeff H; Schmid L
Onkologie; 1985 Oct; 8(5):260-2. PubMed ID: 2999668
[TBL] [Abstract][Full Text] [Related]
19. The biological tumor markers' myopia: a model with CA 125 and second-look in ovarian cancer.
Zanaboni F; Accinelli G; Colombo P; Jelmoni G; Morandi C; Pedronetto S; Sbernini R; Bolis G
Int J Biol Markers; 1987; 2(2):105-8. PubMed ID: 3482860
[TBL] [Abstract][Full Text] [Related]
20. Measurement of serum CA 125 in ovarian cancers.
Yuan CC; Ng HT; Yeh SH; Jeng FS; Chen SL; Tsai LC
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):153-60. PubMed ID: 3484240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
